The University Grants Commission (UGC) has approved 101 universities and 20 Category-I institutions to offer open and distance learning (ODL) programmes for the academic year 2025-26, to be commenced ...

All eyes are on the chip maker as it prepares a full-court press into a new process technology, spearheaded by chips for ...

The University Grants Commission (UGC) has approved 101 universities and 20 Category-I institutions to offer Open and Distance Learning (ODL) programmes for the academic year 2025-26, which will ...

The UGC has officially recognized 101 universities and 20 Category-1 institutions for Open and Distance Learning (ODL) and 113 for online courses for the 2025-26 academic year. Most universities no ...

Get any of our free daily email newsletters — news headlines, opinion, e-edition, obituaries and more. A ballot initiative proposed by a group of Bozeman residents promises to rewire the way ...

DT-101 is designed to allow effective modulation of the AMPA receptor without compromising safety Phase 2 clinical trial initiation anticipated before the end of 2025 Trial builds on positive Phase 1 ...

To submit school announcements, click on image.Make It Haverhill is offering free classes this fall in Job and Tech Skills as well as Computer Basics for beginners. The eight-week class schedule ...

SAN DIEGO, September 24, 2025--(BUSINESS WIRE)--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced top-line results from the Phase 3 COMPASS PWS trial evaluating the efficacy and safety of ...

Support our Mission. We independently test each product we recommend. When you buy through our links, we may earn a commission. One of the most overlooked fundamentals in golf is alignment. Even ...

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...

KSI-101 showed significant visual and anatomical improvements in MESI and DME, with a favorable safety profile in the APEX study. The bispecific mechanism of KSI-101 targets IL-6 and VEGF, offering ...

Meaningful vision gains are rapidly achieved as early as week 4 and more than half of patients in the top two dose levels improved 3-lines or more on the eye chart (≥15 letter gain) A single dose of ...